We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAiq Limited Regulatory News (AIQ)

Share Price Information for Aiq Limited (AIQ)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.00
Bid: 1.00
Ask: 5.00
Change: 0.00 (0.00%)
Spread: 4.00 (400.00%)
Open: 3.00
High: 3.00
Low: 3.00
Prev. Close: 3.00
AIQ Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Final Results and Publication of Annual Report

27 Jan 2020 14:10

RNS Number : 9788A
AIQ Limited
27 January 2020
 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF EU REGULATION 596/2014.

27 January 2020

For Immediate Release

AIQ Limited

("AIQ" or the "Company")

Final Results and Publication of Annual Report

AIQ Limited, a special purpose acquisition company formed to undertake one or more acquisitions of a company or business in the e-commerce sector, announces its final results for the year ended 31 October 2019.

 

Highlights

·; Entered into conditional, non-binding heads of terms to acquire the entire issued share capital of Alchemist Codes Sdn. Bhd. for a non-cash consideration of approximately £2.3 million

·; Net loss reduced to £503,608 (2018: £654,276 loss)

·; Strong cash position of £3.7 million at 31 October 2019 (31 October 2018: £4.1 million)

·; Basic loss per share of 1.0 pence (2018: 1.6 pence loss)

 

Chairman's Statement

 

I am pleased to present the final results of AIQ Limited for the year ended 31 October 2019.

 

During the year, the Board remained active in its search for acquisition opportunities. The Directors reviewed a number of opportunities in the e-commerce, social media and artificial intelligence sectors, and in September signed non-binding heads of terms to acquire the entire issued share capital of Alchemist Codes Sdn. Bhd. ("Alchemist" or "Al Codes") for a consideration of approximately £2.3 million to be satisfied through the issue of new ordinary shares in the Company (the "Potential Acquisition").

 

Alchemist is a Malaysian incorporated information technology solutions developer for the e-commerce sector. Alchemist has two primary lines of business: an IT consultancy business, which engages in online app development for clients, and an e-commerce app, OCTAPLUS, which leverages proprietary data analytic tools, including artificial intelligence technology, for user targeting. Alchemist's key customer regions are currently Malaysia, Singapore and Hong Kong, with expansion plans to grow into China and Europe.

 

The Potential Acquisition is conditional upon, among other things, the completion of satisfactory due diligence, the negotiation and the entry into of legal documentation, any requisite third party consents being obtained and (as described further below) the readmission of the Company's enlarged share capital to the Standard Listing segment of the Official List of the Financial Conduct Authority (the "FCA"), and return to trading of the Ordinary Shares (existing and new) on the London Stock Exchange's (the "LSE") Main Market for listed securities.

 

Due to the nature of the Potential Acquisition, it will constitute a reverse takeover under the FCA's Listing Rules since, inter alia, in substance it will result in a fundamental change in the business of the Company. As a consequence, the Company requested the suspension of the listing in the Ordinary Shares on the Standard Listing segment of the Official List of the FCA, and trading in the Ordinary Shares on the LSE's Main Market for listed securities was suspended with effect from 16 September, until the Company publishes a prospectus in relation to the Potential Acquisition or it being announced that the Potential Acquisition will not proceed.

 

On behalf of the Board, I would like to thank our shareholders for their continued support and we very much look forward to updating the market at the earliest opportunity regarding progress in our negotiations with Alchemist.

 

Graham Duncan

Non-Executive Chairman 

Financial Review

 

The net loss for the year ended 31 October 2019 was £503,608 (2018: £654,276 loss), comprising day-to-day administrative expenses of £487,791 (2018: £381,806) and foreign exchange losses of £35,630 (2018: £147,078 gain). The reduction in loss compared with 2018 is primarily due to the transaction costs of £438,096 in the earlier period associated with the Company's Standard Listing. The increase in administrative expenses primarily resulted from consultancy and professional fees in relation to identifying and assessing acquisition targets. In addition, there was a full year of operations for 2019 compared with approximately ten months in the comparative period from the Standard Listing on 9 January 2018 to 31 October 2018.

 

As a result of the lower net loss, the loss per share was reduced to 1.0 pence (2018: 1.6 pence loss).

 

The Company had a strong cash position of £3.7 million at 31 October 2019 compared with £4.1 million at 31 October 2018.

 

Dividends

 

The Directors do not propose a dividend for the year ended 31 October 2019.

 

 

Growth Strategy and Outlook

 

The Company's near-term goals are to execute its acquisition strategy. In the event of the completion of the Potential Acquisition, the Board expects the immediate focus to be on increasing the registered user base of OCTAPLUS via social media-based marketing while seeking to raise awareness of Alchemist and OCTAPLUS through broader marketing and supporting development of the business through targeted recruitment. The Board looks forward to updating the market, as applicable, in due course.

 

 

Publication of Annual Report

 

The Company's annual report and accounts for the year ended 31 October 2019 has been published today and is available on the AIQ website at: http://www.aiqhub.com/web/investor.php.

STATEMENT OF COMPREHENSIVE INCOME

 

 

 

 

 

 

 

 

 

 

 

Note

 

 

Year ended

31 October 2019

 

£

Period from

11 October 2017 to

31 October 2018

 

£

Administrative expenses

7

 

(487,791)

(381,806)

Transaction costs

13

 

-

(438,096)

(Losses) / gains on foreign exchange (net)

 

 

(35,630)

147,078

Operating loss

 

 

(523,421)

(672,824)

 

 

 

 

 

Finance income

 

 

19,813

18,548

Loss before taxation

7

 

(503,608)

(654,276)

Taxation

9

 

-

-

Loss and total comprehensive income for the year/period

 

 

 

(503,608)

 

(654,276)

 

 

 

 

 

Loss per share - basic and diluted (£ per share)

10

 

(0.010)

(0.016)

        

 

The accompanying notes form an integral part of these financial statements.

 

 

 

STATEMENT OF FINANCIAL POSITION

As at 31 October

 

 

Note

 

 

31 Oct 2019

£

31 Oct 2018

£

Assets

 

 

 

 

 

Current assets

 

 

 

 

 

Rental deposit

 

 

12,300

15,708

Cash and cash equivalents

11

 

 

3,703,592

4,103,928

Total current assets

 

 

 

3,715,892

4,119,636

Total assets

 

 

 

3,715,892

4,119,636

 

Equity and liabilities

 

 

 

 

 

Capital and reserves

 

 

 

 

 

Ordinary shares

13

 

 

518,394

518,394

Share premium

 

 

 

3,848,420

3,848,420

Accumulated losses

 

 

 

(1,157,884)

(654,276)

Total equity

 

 

 

3,208,930

3,712,538

 

 

 

 

 

 

Liabilities

 

 

 

 

 

Current liabilities

 

 

 

 

 

Accruals and other payables

 

 

218,151

118,287

Amounts due to a director

12

 

 

288,811

288,811

Total current liabilities

 

 

 

506,962

407,098

 

 

 

 

 

 

Total equity and liabilities

 

 

 

3,715,892

4,119,636

       

 

The accompanying notes form an integral part of these financial statements.

The financial statements were approved and authorised for issue by the Board of Directors on 24 January 2020 and signed on its behalf by:

 

Soon Beng Gee (Nicholas)

 

Director

 

 

 

 

STATEMENT OF CHANGES IN EQUITY

For the year ended 31 October 2019

 

 

 

 

 

Share

capital

Share premium

 

Accumulated losses

 

Total equity

 

 

£

£

 

£

 

£

 

On incorporation

 

 

152

 

-

 

 

-

 

 

152

Total comprehensive loss for the financial period

 

 

 

-

 

-

 

 

(654,276)

 

 

(654,276)

Issue of shares during the period

518,242

3,848,420

 

-

 

4,366,662

Balance at 31 October 2018

518,394

3,848,420

 

(654,276)

 

3,712,538

Total comprehensive loss for the financial year

 

 

 

-

 

-

 

 

(503,608)

 

 

(503,608)

Balance at 31 October 2019

518,394

3,848,420

 

(1,157,884)

 

3,208,930

 

 

The accompanying notes form an integral part of these financial statements.

 

STATEMENT OF CASH FLOWS FOR THE YEAR ENDED 31 OCTOBER 2019

 

 

 

 

 

 

 

 

Year ended

31 October 2019

£

 

 

 

 

Period from

11 October 2017 to

31 October 2018

£

Cash flows from operating activities

 

 

 

 

Loss before taxation

 

(503,608)

 

(654,276)

Adjustment for:-

 

 

 

 

Interest income

 

(19,813)

 

(18,548)

Loss / (gain) on foreign exchange

 

35,630

 

(147,078)

Operating loss before working capital changes

 

(487,791)

 

(819,902)

Decrease / (increase) in receivables

 

3,408

 

(15,708)

Increase in payables

 

99,864

 

118,287

Increase in amount owing to a director (Note 15)

 

-

 

288,811

Cash used in operations

 

(384,519)

 

(428,512)

Interest received

 

19,813

 

18,548

 

Net cash used in operating activities

 

 

(364,706)

 

 

(409,964)

 

 

 

 

 

Cash flows from financing activities

 

 

 

 

Proceeds from issue of ordinary shares

 

-

 

4,366,814

 

Net cash generated from financing activities

 

 

-

 

 

4,366,814

 

 

 

 

 

Net (decrease) / increase in cash and cash equivalents

 

(364,706)

 

3,956,850

Cash and cash equivalents at beginning of the period

 

4,103,928

 

-

Effect of exchange rates on cash and cash equivalents

 

(35,630)

 

147,078

 

Cash and cash equivalents at end of the period

 

 

3,703,592

 

 

4,103,928

 

 

 

       

 

The accompanying notes form an integral part of these financial statements.

 

NOTES TO THE FINANCIAL STATEMENTS

 

1. GENERAL INFORMATION

AIQ Limited ("The Company") was incorporated and registered in The Cayman Islands as a private company limited by shares on 11 October 2017 under the Companies Law (as revised) of The Cayman Islands, with the name AIQ Limited, and registered number 327983.

The Company's registered office is located at 5th Floor Genesis Building, Genesis Close, PO Box 446, Cayman Islands, KY1-1106.

The Company has a standard listing on the London Stock Exchange.

2. PRINCIPAL ACTIVITIES

The principal activity of the Company is to seek acquisition opportunities, initially focusing on the e-commerce sector.

3. ACCOUNTING POLICIES

a) Basis of preparation

The financial statements have been prepared in accordance with International Financial Reporting Standards as adopted by the European Union.

The comparative figures for the Statement of Comprehensive Income are for a period from 11 October 2017 to 31 October 2018 and consequently are not directly comparable.

The Company has adopted all standards and interpretations which became effective during the period, none of which had a significant impact on these financial statements.

 

IFRSs published but not yet effective 

At the date of authorisation of the financial statements, certain new standards, amendments and interpretations to existing standards applicable to the Company have been published but are not yet effective.

The Directors anticipate that the adoption of such IFRSs in future periods, if applicable, will not have a material impact on the financial statements of the Company in the period of initial adoption.

b) Going concern

The Company meets its day-to-day working capital requirements through cash generated from the capital it has raised on admission to the London Stock Exchange and subsequently. It has £3.7 million in cash which is sufficient for its present needs.

Taking its cash position into account, the Directors are satisfied that the Company has adequate resources to continue in operational existence for the foreseeable future and for a period of not less than 12 months. Thus, they continue to adopt the going concern basis of accounting in preparing the financial statements.

c) Foreign currency transactions and translation

In preparing the financial statements, transactions in currencies other than the Company's functional currency are recorded at the rate of exchange prevailing on the date of the transaction.

The functional currency of the Company is the British Pound Sterling. This is based on the principal currency of expenditure and the Company's equity raise, all being in Sterling. At the end of each financial year, monetary items denominated in foreign currencies are retranslated at the rates prevailing as of the end of the financial year.

Foreign currency transactions are translated into the functional currency using the exchange rates prevailing at the dates of the transactions. Foreign exchange gains and losses resulting from the settlement of such transactions and from the translation at year end exchange rates of monetary assets and liabilities denominated in foreign currencies are recognised in profit or loss.

d) Financial instruments

Financial assets and financial liabilities are recognised in the Statement of Financial Position when the Company becomes a party to the contractual provisions of the instruments. Financial assets and financial liabilities are initially measured at fair value.

Transaction costs that are directly attributable to the acquisition or issue of financial assets and financial liabilities (other than financial assets and financial liabilities at fair value through profit or loss) are added to or deducted from the fair value of the financial assets or financial liabilities, as appropriate, on initial recognition.

Non-derivative financial instruments

Non-derivative financial instruments comprise trade and other receivables, cash and cash equivalents, and trade and other payables.

Trade and other receivables

Trade and other receivables are recognised initially at fair value. Subsequent to initial recognition they are measured at amortised cost using the effective interest method, less any impairment losses.

Trade and other payables

Trade and other payables are recognised initially at fair value. Subsequent to initial recognition they are measured at amortised cost using the effective interest method.

Cash and cash equivalents

Cash and cash equivalents comprise cash balances and call deposits.

e) Financial assets

(i) Initial recognition and measurement

The Company classifies its existing financial assets as financial assets carried at amortised cost. The classification depends on the nature of the assets and the purpose for which the assets were acquired. Management determines the classification of its financial assets at initial recognition and this designation at every reporting date.

Financial assets carried at amortised cost

Financial assets carried at amortised cost are non-derivative financial assets with fixed or determinable payments that are not quoted in an active market. They are presented as current assets, except for those expected to be realised later than twelve months after the reporting date which are classified as non-current assets. They include cash and bank balances, and a rental deposit.

Subsequent to initial recognition, these assets are measured at amortised cost using the effective interest rate method, less impairment.

Impairment of financial assets is considered using a forward-looking expected credit loss (ECL) review.

(ii) De-recognition

Financial assets are de-recognised when the contractual rights to receive cash flows from the financial assets have expired or have been transferred and the Company has transferred substantially all the risks and rewards of ownership. On de-recognition of a financial asset in its entirety, the difference between the carrying amount and the sum of the consideration received and any cumulative gain or loss that had been recognised in other comprehensive income is recognised in profit or loss.

f) Financial liabilities

The Company's financial liabilities include amounts due to a director and other payables and accruals. Financial liabilities are recognised when the Company becomes a party to the contractual provision of the instrument. All financial liabilities are recognised initially at their fair value, net of transaction costs, and subsequently measured at amortised cost, using the effective interest method, unless the effect of discounting would be insignificant, in which case they are stated at cost.

The Company derecognises financial liabilities when, and only when, the Company's obligations are discharged, cancelled or they expire.

g) Share capital

Proceeds from issuance of ordinary shares are classified as equity. Amounts in excess of the nominal value of the shares issued is recognised as share premium.

Transaction costs that are directly attributable to the issue of share capital are deducted from share premium.

h) Current and deferred income tax

The income tax expense or credit for the period is the tax payable on the current period's taxable income based on the applicable income tax rate adjusted by changes in deferred tax assets and liabilities attributable to temporary differences and to unused tax losses. The Company is incorporated in the Cayman Islands, and its activities are subject to taxation at a rate of 0%. Therefore, the Company's activities are not currently exposed to taxation.

i) Cash and cash equivalents

For the purpose of presentation in the statement of cash flows, cash and cash equivalents include cash on hand, deposits held at call with financial institutions, and other short-term highly liquid investments with original maturities of three months or less that are readily convertible to known amounts of cash and which are subject to an insignificant risk of changes in value.

j) Leases

Payments made under operating leases are recognised in the income statement on a straight-line basis over the term of the lease. Lease incentives received are recognised in the income statement as an integral part of the total lease expense.

k) Finance income and expense

Finance income comprises interest receivable on funds invested.

Interest income and interest payable is recognised in profit or loss as it accrues, using the effective interest method.

l) Earnings per share

Basic earnings per share is computed using the weighted average number of shares outstanding during the period. Diluted earnings per share is computed using the weighted average number of shares during the period plus the dilutive effect of dilutive potential ordinary shares outstanding during the period.

4. ACCOUNTING ESTIMATES AND JUDGEMENTS

Preparation of financial information in conformity with IFRSs as adopted by the European Union requires management to make judgements, estimates and assumptions that affect the application of accounting policies and the reported amounts of assets, liabilities, income and expenses. The estimates and associated assumptions are based on historical experience and various other factors that are believed to be reasonable under the circumstances, the results of which form the basis of making judgements about carrying values of assets and liabilities that are not readily apparent from other sources.

It is the Directors' view that there are no significant areas of estimation, uncertainty and critical judgements in applying accounting policies that have significant effect on the amount recognised in the financial information for the period.

5. FINANCIAL RISK MANAGEMENT

a) Categories of financial instruments

The carrying amounts and fair value of the Company's financial assets and liabilities as at the end of the reporting period are as follows:

Financial assets:

 

 

As at

As at

 

31 October

2019

31 October

2018

 

£

£

 

Rental deposit

12,300

15,708

 

Cash and cash equivalents

3,703,592

4,103,928

 

 

3,715,892

4,119,636

      

 

Financial liabilities at amortised cost:

 

 

As at

As at

 

31 October

2019

31 October

2018

 

£

£

 

Accruals and other payables

218,151

118,287

 

Amounts due to a director

288,811

288,811

 

 

506,962

407,098

      

 

The financial assets and financial liabilities maturing within the next 12 months approximate their fair values due to the relatively short-term maturity of the financial instruments.

b) Financial risk management objectives and policies

The Company is exposed to a variety of financial risks: market risk (including interest rate risk and currency risk), credit risk and liquidity risk. The risk management policies employed by the Company to manage these risks are discussed below. The primary objectives of the financial risk management function are to establish risk limits, and then ensure that exposure to risk stays within these limits. The operational and legal risk management functions are intended to ensure proper functioning of internal policies and procedures to minimise operational and legal risks.

i) Interest rate risks

Certain cash holdings and cash equivalents are held in accounts with variable rates. If interest rates were to increase or decrease by 1%, the effect would be to increase/decrease interest income by approximately £30,000 (2018: £30,000) per annum.

ii) Currency risks

The Company is exposed to exchange rate fluctuations as certain transactions are denominated in foreign currencies.

At 31 October 2019 the Company had £3,036,744 (2018: £3,095,270) of cash and cash equivalents in a United States Dollar account. At 31 October 2019, had the exchange rate between the Pound Sterling and United States Dollar increased/decreased by 10%, the effect on the result in the period would be a gain of £303,674 (2018: £309,527) / loss of £303,674 (2018: £309,527).

iii) Credit risk

Credit risk refers to the risk that a counterparty will default on its contractual obligations resulting in financial loss to the Company. Credit allowances are made for estimated losses that have been incurred by the reporting date. No such amounts have been made to date.

Concentrations of credit risk exist to the extent that the Company's cash balances were all held with RHB Bank Berhad in Singapore.  

S&P Global Ratings affirmed on 31 October 2019 the issuer credit ratings of RHB Bank Bhd at BBB+/Stable/A-2, while their ASEAN regional scale ratings were affirmed at "axA+"/"axA-1."

iv) Liquidity risk

Liquidity risk is the risk that the Company will encounter difficulty in meeting the obligations associated with its financial liabilities. The Company's approach to managing liquidity is to ensure, as far as possible, that it will always have sufficient liquidity to meet its liabilities when due, under both normal and stressed conditions, without incurring unacceptable losses or risking damage to the Company's reputation.

The Company's financial liabilities are primarily amounts due to a director. The amounts are unsecured, interest-free and repayable on demand. There are no immediate plans for these amounts to be settled.

 

6. SEGMENT REPORTING

AIQ Limited has no activities at present other than reviewing possible investment opportunities. 

7. OPERATING LOSS BEFORE TAXATION

Loss from operations has been arrived at after charging:

 

 

 

 

 

 

 

 

 

 

 

 

Year

ended

31 October

2019

Period from 11 October 2017

to 31 October 2018

 

 

 

 

 

£

£

 

Auditor's remuneration:

- Audit of the financial statements

- Reporting accountant and transaction services

- Other services

 

33,000

 

35,875

 

3,000

 

18,000

 

52,800

 

-

 

 

 

 

 

 

 

 

Year

ended

31 October

2019

 

 

Period from 11 October 2017

to 31 October 2018

Administrative expenses:

 

 

 

 

£

£

 

Directors' remuneration

139,000

115,833

 

Consultancy fees

115,727

-

 

Office rental

30,104

39,192

 

Professional fees

41,583

-

 

Regulatory fees

20,227

19,781

 

Secretarial fees

28,849

48,092

 

Pre-incorporation costs

-

16,165

 

Audit fees

33,000

18,000

 

Bookkeeping costs

24,000

11,000

 

Share service fees

15,221

43,081

 

Other costs

40,080

70,662

 

 

487,791

381,806

                 

 

8. STAFF COSTS AND KEY MANAGEMENT EMOLUMENTS

 

Key management emoluments

 

Year ended

31 October

2019

Period from 11 October 2018

 

 

to 31 October 2018

 

£

£

 

Remuneration

139,000

115,833

     

 

Included within accruals is £154,000 (2018: £70,000), which relates to remuneration of the Executive Directors, who have not yet taken payment for their fees. The Company did not have any employees during the year ended 31 October 2019 or the period ended 31 October 2018.

9. TAXATION

The Company is incorporated in the Cayman Islands, and its activities are subject to taxation at a rate of 0%.

10. LOSS PER SHARE

The Company presents basic and diluted loss per share information for its ordinary shares. Basic loss per share is calculated by dividing the loss attributable to ordinary shareholders of the Company by the weighted average number of ordinary shares in issue during the reporting period. Diluted earnings per share are determined by adjusting the profit or loss attributable to ordinary shareholders and the weighted average number of ordinary shares outstanding for the effects of all dilutive potential ordinary shares.

There is no difference between the basic and diluted earnings per share, as the Company has no potential ordinary shares.

 

 

 

 

 

Year ended 31 October 2019

Period from

11 October 2017 to 31 October 2018

 

 

 

 

 

 

 

Loss attributable to ordinary shareholders (£)

 

 

(503,608)

(654,276)

 

Weighted average number of shares

 

 

51,839,375

41,007,680

 

Loss per share (expressed as £ per share)

 

 

(0.010)

(0.016)

 

 

 

 

 

 

       

11. CASH AND CASH EQUIVALENTS

 

 

 

 

31 October

 2019

31 October

 2018

 

 

 

 

£

 

£

 

Cash at bank 

 

 

 

3,703,592

4,103,928

 

 

 

 

 

 

 

 Cash at bank earns interest at floating rates based on daily bank deposit rates.

 

12. AMOUNTS DUE TO A DIRECTOR

 

 

 

 

31 October

 2019

31 October

 2018

 

 

 

 

£

 

£

 

Amounts due to a director 

 

 

 

288,811

288,811

 

 

 

 

 

 

 

The amounts due to a director are unsecured, interest free and repayable on demand. The balance arose from administrative expenses and transaction costs settled by the director on behalf of the Company in the period ended 31 October 2018, prior to the Company's bank account being opened.

 

13. SHARE CAPITAL

 

 

Number

Nominal

value

£

 

Authorised

 

 

 

Ordinary shares of £0.01 each

800,000,000

8,000,000

 

 

 

 

 

Issued and fully paid

 

 

 

On incorporation - 200 shares of US$1.00 each

200

152

 

 

Subdivided share capital into £0.01 each

 

15,160

 

152

 

Issue of shares in the period ended 31 October 2018

51,824,215

518,242

 

At 31 October 2018 and 31 October 2019

51,839,375

518,394

 

The holders of Ordinary Shares are entitled to receive dividends as declared from time to time and are entitled to one vote per share at meetings of the Company.

The transaction costs expensed in the period ended 31 October 2018 related to the costs of admission to the Official List of the London Stock Exchange. These principally involved the listing of shares already issued; hence the costs were not directly related to the issue of equity instruments.

14. LEASE COMMITMENTS

As at the reporting date, the Company had commitments for future minimum lease payments under non-cancellable operating leases as follows:

 

 

As at

As at

 

31 October

2019

31 October

2018

 

£

£

Within one year

-

10,008

 

-

10,008

    

 

Amount recognised in profit or loss:

Lease expenses

30,014

39,912

 

These lease commitments related to the lease of the Company's office which was terminated in the year.

 

15. NOTE TO THE STATEMENT OF CASH FLOWS

Reconciliation of amounts due to a director

 

 

Director's loan

£

Balance at 11 October 2017

-

Settlement of payables on behalf of the Company (note 12)

288,811

Balance at 31 October 2018 and 31 October 2019

288,811

 

16. SUBSEQUENT EVENTS

There are no events subsequent to the year-end that require disclosure in these financial statements.

 

17. CAPITAL MANAGEMENT

The Company manages its capital to ensure that it will be able to continue as a going concern while maximising the return to shareholders through the optimisation of the balance between debt and equity.

 

The capital structure of the Company as at 31 October 2019 consisted of Ordinary Shares and equity attributable to the shareholders of the Company, totalling £3,208,930 (2018: £3,712,538) (disclosed in the statement of changes in equity).

 

The Company reviews the capital structure on an on-going basis. As part of this review, the directors consider the cost of capital and the risks associated with each class of capital. The Company will balance its overall capital structure through the payment of dividends, new share issues and the issue of new debt or the repayment of existing debt.

 

18. RELATED PARTY TRANSACTIONS

The remuneration of the Directors, the key management personnel of the Company, is set out in Note 8.

 

A total £21,000 (2018: £15,000) was paid during the year to Luther Pendragon Limited for financial PR services, a company in which Harry Chathli is a director and shareholder.

 

As at 31 October 2019, there is a balance due to a director of £288,811 (2018: £288,811) (see Note 12).

 

19. ULTIMATE CONTROLLING PARTY

As at 31 October 2019, no one entity owns greater than 50% of the issued share capital. Therefore, the Company does not have an ultimate controlling party.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
FR MZGZMNNZGGZG
12
Date   Source Headline
25th Mar 20244:00 pmRNSNotice of AGM
28th Feb 20247:00 amRNSFinal Results and Publication of Annual Report
31st Jul 20237:00 amRNSStatement re. Convertible Loan Note Facility
31st Jul 20237:00 amRNSInterim Results
18th Apr 202311:20 amRNSResult of Annual General Meeting
27th Mar 20237:00 amRNSNew Contract
20th Mar 20237:00 amRNSNotice of AGM
28th Feb 20231:50 pmRNSFinal Results and Publication of Annual Report
24th Feb 20231:28 pmRNSChange of Auditor
23rd Nov 20222:05 pmRNSSecond Price Monitoring Extn
23rd Nov 20222:00 pmRNSPrice Monitoring Extension
6th Oct 202211:05 amRNSSecond Price Monitoring Extn
6th Oct 202211:00 amRNSPrice Monitoring Extension
6th Oct 20227:00 amRNSDirectorate Change
3rd Oct 202212:15 pmRNSAppointment of Financial Adviser
1st Aug 202211:06 amRNSSecond Price Monitoring Extn
1st Aug 202211:00 amRNSPrice Monitoring Extension
29th Jul 20227:00 amRNSInterim Results
14th Apr 202210:46 amRNSResult of AGM
22nd Mar 20227:00 amRNSNew contract and partnerships for NFT marketplace
17th Mar 20227:00 amRNSNotice of AGM
28th Feb 20223:17 pmRNSFinal Results and Publication of Annual Report
28th Feb 20227:00 amRNSFinal Results and Publication of Annual Report
25th Jan 202210:13 amRNSIssue of Convertible Loan Notes to raise £500,000
29th Nov 20212:06 pmRNSSecond Price Monitoring Extn
29th Nov 20212:00 pmRNSPrice Monitoring Extension
29th Nov 202111:06 amRNSSecond Price Monitoring Extn
29th Nov 202111:00 amRNSPrice Monitoring Extension
24th Nov 202111:05 amRNSSecond Price Monitoring Extn
24th Nov 202111:00 amRNSPrice Monitoring Extension
24th Nov 20219:05 amRNSSecond Price Monitoring Extn
24th Nov 20219:00 amRNSPrice Monitoring Extension
11th Nov 20212:05 pmRNSSecond Price Monitoring Extn
11th Nov 20212:00 pmRNSPrice Monitoring Extension
22nd Oct 20212:13 pmRNSResponse to Share Price Movement
22nd Oct 20212:00 pmRNSPrice Monitoring Extension
4th Oct 20217:00 amRNSNew contract to supply DeFi DEX
30th Jul 20217:00 amRNSInterim Results
15th Jun 20217:00 amRNSResult of Strategic Review
28th May 202111:00 amRNSResult of AGM
11th May 20219:30 amRNSNotice of AGM
30th Apr 20217:00 amRNSFinal Results and Publication of Annual Report
21st Apr 20217:00 amRNSDirector Shareholding
18th Feb 20219:05 amRNSSecond Price Monitoring Extn
18th Feb 20219:00 amRNSPrice Monitoring Extension
17th Feb 20217:00 amRNSPublication of Results
30th Dec 20207:00 amRNSDirectorate Change
30th Jul 20207:00 amRNSInterim Results
31st Mar 20201:56 pmRNSResponse to Share Price Movement
26th Mar 20207:00 amRNSAcquisition completion and restoration of trading
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.